Clinuvel Pharmaceuticals Ltd (CUV) — Cash Flow Reinvestment Rate
Clinuvel Pharmaceuticals Ltd (CUV) has a Cash Flow Reinvestment Rate of 0.01x as of December 2025, reinvesting AU$149.47K (capex AU$149.47K ) from operating cash flow of AU$12.52 Million. Explore capital reinvestment ratio of Clinuvel Pharmaceuticals Ltd to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Clinuvel Pharmaceuticals Ltd Cash Flow Reinvestment Rate (2017–2025)
Historical reinvestment intensity for Clinuvel Pharmaceuticals Ltd across 9 annual periods. Also explore Clinuvel Pharmaceuticals Ltd asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Clinuvel Pharmaceuticals Ltd (2017–2025)
Year-by-year capital reinvestment analysis for Clinuvel Pharmaceuticals Ltd. For live market cap and broader valuation context, see Clinuvel Pharmaceuticals Ltd market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (AUD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 1.17x | AU$48.01 Million | AU$41.10 Million | AU$298.57K | ▲ +25.1% |
| 2024 | 0.93x | AU$34.61 Million | AU$37.05 Million | AU$5.58 Million | ▲ +1577.7% |
| 2023 | 0.06x | AU$2.06 Million | AU$36.91 Million | AU$1.03 Million | ▲ +155.5% |
| 2022 | 0.02x | AU$868.88K | AU$39.87 Million | AU$434.44K | ▼ -75.4% |
| 2021 | 0.09x | AU$1.71 Million | AU$19.26 Million | AU$854.33K | ▼ -29.2% |
| 2020 | 0.13x | AU$1.78 Million | AU$14.19 Million | AU$888.83K | ▲ +348.8% |
| 2019 | 0.03x | AU$515.23K | AU$18.46 Million | AU$257.62K | ▲ +117.3% |
| 2018 | 0.01x | AU$150.25K | AU$11.69 Million | AU$75.12K | ▼ -5.6% |
| 2017 | 0.01x | AU$134.96K | AU$9.92 Million | AU$67.48K | — |